WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 462
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 602

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 24'969  24'407  23'852  23'304  22'763  17'523  11'790  7'907 
Births 767  760  752  745  737  695  620  447 
Surviving infants 725  718  710  702  694  646  565  388 
Pop. less than 5 years 3'496  3'446  3'397  3'360  3'340  3'113  2'535  1'647 
Pop. less than 15 years 9'900  9'806  9'710  9'622  9'549  8'511  6'143  3'878 
Female 15-49 years 6'269  6'077  5'889  5'700  5'506  3'712  2'374  1'704 

Number of reported case

(Click for retrospective incidence data for Yemen)
Diphtheria 555 
Japanese encephalitis
Measles 815  400  2'177  2'676  510  18'020 
Mumps 3'837  5'081  3'306  4'685 
Pertussis 2'529  4'699  2'280  2'534  15'332 
Polio* 722 
Rubella 1'598  706  199  337  187 
Rubella (CRS)
Tetanus (neonatal) 66  80  38  93  174 
Tetanus (total)** 66  115  38  93  405 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Yemen)
Vaccine year result method % card seen                                                
BCG 2005  69  MICS   48  73  69  64  59  65  82  99* 
DTP1 2005  78  MICS   48  94  94  89  89  94  88 
DTP3 2005  61  MICS   48  88  88  82  81  87  76  89 
DTP4         
IPV1         
HepB_BD         
HepB3 2005  19  MICS   48  88  88  82  81  87  15 
Hib3 2005  43  MICS   48  88  88  82  81  87 
JapEnc         
MCV1          75  78  71  71  73  71  74 
MCV2          53  55  48  54  49 
PCV1          93  94  88  81 
PCV3          88  88  82  56 
Pol3 2005  63  MICS   48  88  88  82  81  88  76  89 
Rota1          79  79  35 
Rota_last          72  71  23 
Rubella1         
TT2plus 1996  DHS   31  18  18  13  13  17  31  15 
PAB         
VAD1          59  60  49  65  63 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Yemen)
BCG 73  71  64  59  65  82  95 
DTP1 94  94  89  89  94  88  94  18 
DTP3 88  88  82  81  87  76  84 
HepB3 88  88  82  81  87  15 
HepB_BD
Hib3 88  88  82  81  87 
MCV1 75  78  71  71  73  71  69 
MCV2 53  55  48  54  49 
PAB 70  70  66  66  66  54  17 
PCV3 88  88  82  56 
Pol3 88  88  89  81  88  76  84 
Rota_last 72  71  23 

Number of districts in the country 333  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
97 
   
/
|
|
\
Greater or equal to 90% 46
From 80 to 89% 31
From 50 to 79% 18
Less than 50% 4
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks; Yes From March 2015
MR 9, 18 months; Yes From March 2015
Measles 9, 18 months; Yes
OPV birth; 6, 10, 14 weeks; 9, 18 months; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes
VitaminA 9, 18 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011-2015  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 321  306  321  306  306  333  333 

System performance

Total Nº districts in country number 333  333  333  333  333  333  333 
Nº districts with DTP3 coverage >=80% number 256  255  194  189  249  227  221 
% of districts with DTP3 coverage >=80% From 0 to 100% 77  77  58  57  75  68  66 
Nº districts with measles (MCV1) coverage >=95% number 30  36  22  24  20  13  21 
% of districts with MCV1 coverage >=95% From 0 to 100% 11 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  No  No  No  No  No  No 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 22  17  33  37  43  63  66 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.